CN107898658A - Argireline anti-wrinkle synergy stoste composition - Google Patents
Argireline anti-wrinkle synergy stoste composition Download PDFInfo
- Publication number
- CN107898658A CN107898658A CN201711331041.9A CN201711331041A CN107898658A CN 107898658 A CN107898658 A CN 107898658A CN 201711331041 A CN201711331041 A CN 201711331041A CN 107898658 A CN107898658 A CN 107898658A
- Authority
- CN
- China
- Prior art keywords
- argireline
- wrinkle
- sodium hyaluronate
- synergy
- erythrocuprein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/66—Enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/008—Preparations for oily skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Cosmetics (AREA)
Abstract
A kind of Argireline anti-wrinkle synergy stoste composition, comprise the following raw materials by weight percent, Argireline 8 0.01 0.02%, macromolecule sodium hyaluronate 0.15 0.25%, low molecule sodium hyaluronate 0.1 0.15%, erythrocuprein 0.02 0.04%, arginine 0.01 0.02%, valine 0.01 0.02%, 1.3 butanediols 0.5 1.0%, propane diols 3.0 5.0%, surplus are deionized water.The Argireline anti-wrinkle synergy stoste composition of the present invention, by by Argireline 8 and amino acid, sodium hyaluronate, erythrocuprein etc. organically combines, and anti-wrinkle effect, moisture-keeping efficacy, the water and oil balance and anti-senescence function for controlling skin of Argireline are given full play to more suitable isoelectric point.
Description
Technical field
The invention belongs to cosmetic field, and in particular to a kind of Argireline anti-wrinkle synergy stoste composition.
Background technology
With people's age natural aging, visual appearance, physical characteristic and the physiological function of skin change, in human body
Fibroblastic quantity gradually decreases, therefore the collagen of its secretion and elastic fibers albumen by oxidation also because gradually subtracted
Less, it is broken, skin corium starts thinning, and skin elasticity is deteriorated, and wrinkle also begins to gradually produce.
Argireline is the biogenetic products being composed of six amino acid ranges, is a species creotoxin component, has meat
Toxin repertoire, and any toxicity is free of, it is non-toxicant.Argireline has the signal that can intercept contraction of muscle, mitigates
The power of contraction of muscle, and then improve the depth and length of microgroove, it is preferable for crease-resistant component, effect.But six victory of existing market
Peptide stoste single effect, it is difficult to find, a kind of moistening effect is good and the skin that can compact, and eliminates the product of microgroove.
The content of the invention
Good it is an object of the invention to provide a kind of moistening effect, can compact skin, eliminate the Argireline of skin lines
Anti-wrinkle synergy stoste composition.
The Argireline anti-wrinkle synergy stoste composition of the present invention, comprises the following raw materials by weight percent, Argireline -8
0.01-0.02%, macromolecule sodium hyaluronate 0.15-0.25%, low molecule sodium hyaluronate 0.1-0.15%, erythrocuprein 0.02-
0.04%th, arginine 0.01-0.02%, valine 0.01-0.02%, 1.3- butanediol 0.5-1.0%, propane diols 3.0-5.0%, remaining
Measure as deionized water.
The Argireline anti-wrinkle synergy stoste preparation method of composition of the present invention is, by proportioning by Argireline -8, macromolecule glass
Uric acid, low molecule sodium hyaluronate, erythrocuprein, arginine, valine, 1.3- butanediols, propane diols, surplus are deionization
Water, is stirred filling.
The Argireline anti-wrinkle synergy stoste composition of the present invention, by by Argireline -8 and amino acid, sodium hyaluronate, super oxygen thing
Mutase (Superoxide dismutase abbreviation SOD) etc. organically combines, abundant with more suitable isoelectric point
Play anti-wrinkle effect, moisture-keeping efficacy, the water and oil balance and anti-senescence function for controlling skin of Argireline.
Embodiment
Embodiment 1
A kind of face's external application has anti-wrinkle, moisturizing, the water and oil balance for controlling skin, the stoste composition of anti-senescence function by following
Percentage by weight raw material forms:Argireline -8 0.01%, macromolecule sodium hyaluronate 0.20%, low molecule sodium hyaluronate 0.15%, super oxygen thing
Mutase 0.02%, arginine 0.01%, valine 0.02%, 1.3- butanediols 0.6%, propane diols 3.0%, surplus are deionized water.
Its preparation method is:By proportioning by Argireline -8, macromolecule sodium hyaluronate, low molecule sodium hyaluronate, erythrocuprein,
Arginine, valine, 1.3- butanediols, propane diols, surplus are deionized water, are stirred filling.
Embodiment 2
A kind of face's external application has anti-wrinkle, moisturizing, the water and oil balance for controlling skin, the stoste composition of anti-senescence function by following
Percentage by weight raw material forms:Argireline -80.02%, macromolecule sodium hyaluronate 0.25%, low molecule sodium hyaluronate 0.1%, super oxygen thing discrimination
Change enzyme 0.04%, arginine 0.02%, valine 0.01%, 1.3- butanediols 0.8%, propane diols 5.0%, surplus is deionized water.
Its preparation method is:By proportioning by Argireline -8, macromolecule sodium hyaluronate, low molecule sodium hyaluronate, erythrocuprein,
Arginine, valine, 1.3- butanediols, propane diols, surplus are deionized water, are stirred filling.
Claims (1)
- A kind of 1. Argireline anti-wrinkle synergy stoste composition, it is characterised in that:It is to comprise the following raw materials by weight percent, The 0.01-0.02% of Argireline -8, macromolecule sodium hyaluronate 0.15-0.25%, low molecule sodium hyaluronate 0.1-0.15%, erythrocuprein 0.02-0.04%, arginine 0.01-0.02%, valine 0.01-0.02%, 1.3- butanediol 0.5-1.0%, propane diols 3.0- 5.0%th, surplus is deionized water;Its preparation method is, by proportioning by Argireline -8, macromolecule sodium hyaluronate, low molecule sodium hyaluronate, erythrocuprein, smart ammonia Acid, valine, 1.3- butanediols, propane diols, surplus are deionized water, are stirred filling.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711331041.9A CN107898658A (en) | 2017-12-13 | 2017-12-13 | Argireline anti-wrinkle synergy stoste composition |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711331041.9A CN107898658A (en) | 2017-12-13 | 2017-12-13 | Argireline anti-wrinkle synergy stoste composition |
Publications (1)
Publication Number | Publication Date |
---|---|
CN107898658A true CN107898658A (en) | 2018-04-13 |
Family
ID=61865535
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201711331041.9A Pending CN107898658A (en) | 2017-12-13 | 2017-12-13 | Argireline anti-wrinkle synergy stoste composition |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107898658A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110151585A (en) * | 2019-07-04 | 2019-08-23 | 广东天源生物科技有限公司 | One kind having whitening desalination acne print performance oligopeptides stoste and preparation method thereof |
CN111012729A (en) * | 2020-01-13 | 2020-04-17 | 南京平港健康管理有限公司 | Hyaluronic acid anti-wrinkle stock solution |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101214200A (en) * | 2008-01-21 | 2008-07-09 | 丁克祥 | Skin externally-applied liquid state and solid state kreotoxin (liushengtai) composite nano emulsion and preparation thereof |
CN102015764A (en) * | 2008-02-29 | 2011-04-13 | 利普泰股份公司 | Cosmetic or pharmaceutical compositions comprising metalloproteinase inhibitors |
CN102470160A (en) * | 2009-07-24 | 2012-05-23 | 利普泰股份公司 | Compounds which inhibit muscle contraction |
CN104146945A (en) * | 2014-08-21 | 2014-11-19 | 广州市美立方化妆品有限公司 | Bioactive peptide skin activating, ageing preventing and whitening elite liquid and preparation method thereof |
CN104207977A (en) * | 2014-08-21 | 2014-12-17 | 广州市美立方化妆品有限公司 | Bioactive peptide anti-aging wrinkle-removing sensitivity-relieving essence and preparation method thereof |
CN104983666A (en) * | 2015-07-31 | 2015-10-21 | 桂林市宏旭生物科技有限公司 | Repair and regeneration mask product and preparation method thereof |
CN106109302A (en) * | 2016-07-13 | 2016-11-16 | 广州千百度化妆品有限公司 | A kind of Argireline stock solution and preparation method thereof |
CN106344427A (en) * | 2016-10-13 | 2017-01-25 | 珠海美逸生物科技有限公司 | Polypeptide composition for facial care and preparation method of polypeptide composition |
CN107308020A (en) * | 2017-07-06 | 2017-11-03 | 珠海联邦制药股份有限公司 | A kind of peptide composition of stabilization and its application |
-
2017
- 2017-12-13 CN CN201711331041.9A patent/CN107898658A/en active Pending
Patent Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101214200A (en) * | 2008-01-21 | 2008-07-09 | 丁克祥 | Skin externally-applied liquid state and solid state kreotoxin (liushengtai) composite nano emulsion and preparation thereof |
CN102015764A (en) * | 2008-02-29 | 2011-04-13 | 利普泰股份公司 | Cosmetic or pharmaceutical compositions comprising metalloproteinase inhibitors |
CN102470160A (en) * | 2009-07-24 | 2012-05-23 | 利普泰股份公司 | Compounds which inhibit muscle contraction |
CN104146945A (en) * | 2014-08-21 | 2014-11-19 | 广州市美立方化妆品有限公司 | Bioactive peptide skin activating, ageing preventing and whitening elite liquid and preparation method thereof |
CN104207977A (en) * | 2014-08-21 | 2014-12-17 | 广州市美立方化妆品有限公司 | Bioactive peptide anti-aging wrinkle-removing sensitivity-relieving essence and preparation method thereof |
CN104983666A (en) * | 2015-07-31 | 2015-10-21 | 桂林市宏旭生物科技有限公司 | Repair and regeneration mask product and preparation method thereof |
CN106109302A (en) * | 2016-07-13 | 2016-11-16 | 广州千百度化妆品有限公司 | A kind of Argireline stock solution and preparation method thereof |
CN106344427A (en) * | 2016-10-13 | 2017-01-25 | 珠海美逸生物科技有限公司 | Polypeptide composition for facial care and preparation method of polypeptide composition |
CN107308020A (en) * | 2017-07-06 | 2017-11-03 | 珠海联邦制药股份有限公司 | A kind of peptide composition of stabilization and its application |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110151585A (en) * | 2019-07-04 | 2019-08-23 | 广东天源生物科技有限公司 | One kind having whitening desalination acne print performance oligopeptides stoste and preparation method thereof |
CN111012729A (en) * | 2020-01-13 | 2020-04-17 | 南京平港健康管理有限公司 | Hyaluronic acid anti-wrinkle stock solution |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105125476B (en) | A kind of anti-wrinkle essence and preparation method thereof | |
CN101791283B (en) | Cosmetic capable of eliminating striae gravidarum and scars | |
CN101697954A (en) | Anti-wrinkle emulsion with pearl hydrolyzate liposome | |
CN103421872A (en) | Preparation method and application of crocodile-skin collagen peptide | |
CN104546630A (en) | Wrinkle-removing moisturizing efficient eye cream and preparation method thereof | |
CN109730953A (en) | A kind of hyaluronic acid (sodium hyaluronate) stoste and preparation method thereof | |
CN109260035A (en) | Anti-ageing composition of a kind of whitening containing fullerene and preparation method thereof | |
CN107898658A (en) | Argireline anti-wrinkle synergy stoste composition | |
CN105232377A (en) | Antisenescence facial mask containing matcha powder | |
CN112842985A (en) | Moisturizing and repairing composition | |
CN110063916A (en) | Can Vitamin K, dispel eye pouch and eyeprint composition | |
CN102846508A (en) | Improved revitalizing plant eye cream | |
CN110302081A (en) | A kind of dual sodium hyaluronate stoste and preparation method thereof | |
CN104473841A (en) | Traditional Chinese medicine mask containing dendrobe | |
CN104586650A (en) | Anti-chapping hand cream | |
CN104586711A (en) | Moistening hand cream | |
CN108478464A (en) | A kind of skin makeup peptide facial mask liquid and preparation method thereof | |
CN105560090A (en) | Skin-activating moisturizing anti-wrinkle face-moisturizing cream | |
CN107890455A (en) | A kind of preparation method of the reparation anti-wrinkle facial mask liquid containing snail mucus and sodium hyaluronate | |
CN107822936A (en) | A kind of anti-aging composition of skin wrinkle resisting | |
CN106333874A (en) | Oat hydrating moisturizing sleeping facial mask | |
CN104586656A (en) | Hand cream | |
CN106974880A (en) | A kind of moisturiser based on marine organism extract | |
CN107496194A (en) | A kind of surfactant and preparation method thereof | |
CN110496069A (en) | A kind of poly- peptide stoste of small molecule and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20180413 |